Recombitope peptides
    4.
    发明授权
    Recombitope peptides 失效
    重组单抗肽

    公开(公告)号:US07211408B2

    公开(公告)日:2007-05-01

    申请号:US10463113

    申请日:2003-06-16

    IPC分类号: G01N33/00 C12N15/09 C07K1/00

    摘要: The present invention provides peptides having T cell stimulating activity termed recombitope peptides. Recombitope peptides of the invention preferably comprise at least two T cell epitopes derived from the same or from different protein antigens, and more preferably comprise at least two regions, each region preferably having human T cell stimulating activity and each region comprising at least one T cell epitope derived from a protein antigen. Recombitope peptides of the invention can be derived from protein allergens, autoantigens, or other protein antigens. The invention also provides methods of diagnosing sensitivity to a protein allergen or other protein antigen in an individual, methods to treat such sensitivity and therapeutic compositions comprising one or more recombitope peptides. The invention further provides methods for designing recombitope peptides of the invention where the protein antigen to which the individual is sensitive has unknown or ill-defined T cell epitopes.

    摘要翻译: 本发明提供了称为重组竞争肽的具有T细胞刺激活性的肽。 本发明的重组匹配肽优选包含至少两种衍生自相同或不同蛋白质抗原的T细胞表位,更优选包含至少两个区域,每个区域优选具有人T细胞刺激活性,每个区域包含至少一个T细胞 衍生自蛋白质抗原的表位。 本发明的重组蛋白多肽可以衍生自蛋白质过敏原,自身抗原或其他蛋白质抗原。 本发明还提供诊断个体中蛋白质变应原或其他蛋白质抗原的敏感性的方法,治疗这种敏感性的方法和包含一种或多种重组蛋白多肽的治疗组合物的方法。 本发明还提供了用于设计本发明的重组蛋白肽的方法,其中个体敏感的蛋白质抗原具有未知或不明确的T细胞表位。